Rheumatology Network News Roundup

In this news roundup, we offer a snapshot of some interesting studies we featured that pose never-ending perplexing questions: When do I switch patients from methotrexate to a biologic? Why didn't my patient report having an adverse reaction? Does vitamin D really protect bones?

In this news roundup, we offer a snapshot of some interesting studies we featured that pose never-ending perplexing questions:  When do I switch patients from methotrexate to a biologic? Why didn't my patient report having an adverse reaction? Does vitamin D really protect bones?

Related Videos
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Video 6 - "The Role of Eosinophils in Diagnosing COPD"
Video 5 - "Unmet Needs in the COPD Treatment Landscape"
Video 6 - "Treatment Resistance in HIV"
Video 5 - "Importance of Starting HIV Treatment Early"
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy| Image Credit: University of Chicago
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
Related Content
Greater Salivary Rates Linked to Lower Levels of Psoriasis Disease Severity

Greater Salivary Rates Linked to Lower Levels of Psoriasis Disease Severity

Chelsie Derman
May 31st 2024
Article
Don't Miss a Beat: Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD

Don't Miss a Beat: Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD

Muthiah Vaduganathan, MD, MPH;Stephen Greene, MD
May 29th 2024
Podcast
Patients with Crohn’s Disease Satisfied with Switch to Adalimumab Biosimilar SB5

Patients with Crohn’s Disease Satisfied with Switch to Adalimumab Biosimilar SB5

Lana Pine
May 31st 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
May 25th 2024
Podcast
| Image Credit: LinkedIn

Oral PCSK9 inhibitor Significantly Reduces LDL-C in Hypercholesterolemia

Connor Iapoce
May 31st 2024
Article
Specific Inflammatory Markers Linked to Depression in Patients with Psoriasis

Specific Inflammatory Markers Linked to Depression in Patients with Psoriasis

Chelsie Derman
May 31st 2024
Article
© 2024 MJH Life Sciences

All rights reserved.